| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
| 04/11/2007 | EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 04/11/2007 | EP1014944B1 Biocompatible compounds for pharmaceutical drug delivery systems |
| 04/11/2007 | CN1946743A Hyaluronic acid/methotrexate compound |
| 04/11/2007 | CN1946742A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 04/11/2007 | CN1946429A Adhesive material |
| 04/11/2007 | CN1946428A Therapeutic antimicrobial compositions and methods |
| 04/11/2007 | CN1946427A Liquid growth hormone formulation |
| 04/11/2007 | CN1946426A Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof |
| 04/11/2007 | CN1946394A Injectable composition for the treatment of cancers |
| 04/11/2007 | CN1946387A Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 04/11/2007 | CN1946380A Oral disintegration preparation and its preparing method |
| 04/11/2007 | CN1946378A Combination dosage forms |
| 04/11/2007 | CN1946290A Modified serum albumin with reduced affinity for nickel and copper |
| 04/11/2007 | CN1944460A Alr多肽及其应用 Alr peptide and its application |
| 04/11/2007 | CN1944399A Glycol cyano-acrylate and its preparing method and use |
| 04/11/2007 | CN1943790A Prevention and treatment of restenosis by local administration of drug |
| 04/11/2007 | CN1943787A A damp proof composition for pharmaceutical and its preparation methods |
| 04/11/2007 | CN1943636A A health product for relieving eye tiredness |
| 04/11/2007 | CN1943629A Chinese cassia tree bark oil dripping pill and its preparing method |
| 04/11/2007 | CN1943625A Oral sterilizing liquid |
| 04/11/2007 | CN1943595A Active carbon oral suspension liquid, preparing method and its use |
| 04/11/2007 | CN1943593A External use anti-bacteria foaming agent for gynecology |
| 04/11/2007 | CN1943592A Process for preparing anti-heat stress medicial composition for fowls and use |
| 04/11/2007 | CN1943589A Injection for positioning and promoting fat growth and its preparing method |
| 04/11/2007 | CN1943587A Medicinal slow release agent for treating rabbit infections rhinitis and its preparing method |
| 04/11/2007 | CN1943585A Breviscapine proliposome powder preparation and its preparing method |
| 04/11/2007 | CN1943583A Freeze-dried preparation for treating cerebral vascular disease |
| 04/11/2007 | CN1943578A Medicinal composition containing ceftriaxone sodium and lidocaine hydrochloride injection |
| 04/11/2007 | CN1943576A Buprenorphin and/or buprenorphin hydrochloride plaster substrate and its preparing method for plaster |
| 04/11/2007 | CN1943575A Abuse potential low compound buprenorphin hydrochloride naloxone hydrochloride sublingual tablet |
| 04/11/2007 | CN1943568A Rumen protection amino acid and preparing method |
| 04/11/2007 | CN1943567A Self micro emulsifying composition of tretinoin medicines and its preparing method |
| 04/11/2007 | CN1943566A Curcumin liposome and its method for preparing freeze-dried powder injection |
| 04/11/2007 | CN1943560A Sandwich structure magnetic composite micro ball with functional shell layer, its preparing method and use |
| 04/11/2007 | CN1943559A Deoxyuridine powder injection and its preparing method |
| 04/11/2007 | CN1943557A Process for preparing nano liposome for coating large molecular medicine |
| 04/11/2007 | CN1943541A Supersonic micro bubble skin permeate promotor |
| 04/11/2007 | CN1943539A Skin preparation composition for external use |
| 04/11/2007 | CN1309781C Solid emulsions based on thermoplastic elastomers |
| 04/11/2007 | CN1309763C High-molecular weight derivatives of camptothecins |
| 04/11/2007 | CN1309741C Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 04/11/2007 | CN1309739C New fusion protein as carrier |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309425C Method of treating canker sores with patches to speed healing and relieve pain |
| 04/11/2007 | CN1309423C Interferon gamma conjugates |
| 04/11/2007 | CN1309422C Nanometer particle and medicine capsule of polymeric compound and preparation |
| 04/11/2007 | CN1309416C Pharmaceutical composition |
| 04/11/2007 | CN1309415C Endoparasiticidal agent composition |
| 04/11/2007 | CN1309414C Hydrophilic binary systems for the administration of cyclosporine |
| 04/11/2007 | CN1309381C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309378C Aerosol formulation for inhalation comprising a tiotropium salt |
| 04/11/2007 | CN1309377C Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 04/11/2007 | CN1309374C Improved rapidly disintegratable multiparticulate tablet |
| 04/11/2007 | CN1309370C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202351 Alteration of immune response using pan DR-binding peptides |
| 04/10/2007 | US7202346 Where antibodies and antibody fragments recognize extracellular epitopes of plasma membrane proteins that are not released into the extracellular fluid; methods for detection, monitoring and treatment of cancer |
| 04/10/2007 | US7202340 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 04/10/2007 | US7202330 RGD (Arg-Gly-Asp) coupled to (neuro)peptides |
| 04/10/2007 | US7202281 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202233 Inclusion complex of (a) alprazolam in ring-closed form and (b) a water soluble 2-hydroxypropyl-beta-cyclodextrin, adapted for transmucosal delivery; used for treatment of Generalised Anxiety Disorder |
| 04/10/2007 | US7202227 Multifunctional molecular complexes for gene transfer to cells |
| 04/10/2007 | US7202225 Therapeutic delivery compositions and methods of use thereof |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202078 Composition intended for the preservation of infectious recombinant adenoviruses |
| 04/10/2007 | US7202065 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 04/10/2007 | US7201930 Licorice root extract oral patch for treating canker sores |
| 04/10/2007 | US7201925 Treatment of ungual and subungual diseases |
| 04/10/2007 | US7201923 Nutraceuticals, drugs, contains an active, sensitive encapsulant, such as a live microorganism or an enzyme dissolved or dispersed in a liquid plasticizer is admixed with a plasticizable matrix material; shelf-stable, controlled release, discrete, solid particles from a liquid encapsulant |
| 04/10/2007 | US7201922 Codried granules of lactose and starch with an active substance |
| 04/10/2007 | US7201921 A filling formualtion for soft capsule dosage containing loratadine and derivative, a mixture of mono and diglyceride of medium chain fatty acids, povidone and polyoxyethylene sorbitan fatty ester; capsule material is carrageenan |
| 04/10/2007 | US7201919 Mixture for transdermal delivery of low and high molecular weight compounds |
| 04/10/2007 | US7201914 May contain a viricide, a bactericide or bacteriostate, and/or an antiinflammatory agent; uses include control of microbial growth on gloved hands |
| 04/10/2007 | US7201913 Oral formulations for anti-tumor compounds |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | US7201897 Interferon conjugates |
| 04/10/2007 | US7201890 Parenterally injecting patient with labeled divalent single chain antibody fragment or subfragment; conducting procedure within 48 hours of the injection; scanning the accessed interior locating sites of accretion of labeled antibody |
| 04/10/2007 | US7201765 Method and apparatus for acne treatment |
| 04/10/2007 | CA2403869C Method for treating dry eye |
| 04/10/2007 | CA2321969C Process for the production of encased, spherical granular grains |
| 04/10/2007 | CA2300281C Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 04/10/2007 | CA2278684C Thimerosal-free preservatives for vaccines |
| 04/10/2007 | CA2251944C Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 04/10/2007 | CA2200061C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 04/10/2007 | CA2198240C Topical ketoconazole emulsions |
| 04/10/2007 | CA2189424C Non-steroidal anti-inflammatory ophthalmic suspensions |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2145093C Therapeutic inhibitor of vascular smooth muscle cells |
| 04/10/2007 | CA2138351C Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 04/07/2007 | CA2562767A1 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 04/05/2007 | WO2007038796A1 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 04/05/2007 | WO2007038768A2 Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome |
| 04/05/2007 | WO2007038627A2 Stabilized antimicrobial compositions and related methods of preparation |
| 04/05/2007 | WO2007038596A2 Phytosterol nutritional supplements |
| 04/05/2007 | WO2007038172A2 Guanidinium carriers |